Study Stopped
Management decision
DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study
1 other identifier
observational
192
1 country
12
Brief Summary
The purpose of this study is to continuously assess the visual performance and safety of DAILIES TOTAL1 soft contact lenses in a real world setting and broader patient base through routine clinical practices. This activity will be used to continuously support delefilcon A (sphere, toric, and multifocal) soft contact lens regulatory requirements and standards.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2024
Shorter than P25 for all trials
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2024
CompletedFirst Posted
Study publicly available on registry
July 3, 2024
CompletedStudy Start
First participant enrolled
November 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2025
CompletedJuly 20, 2025
July 1, 2025
3 months
June 26, 2024
July 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Distance visual acuity (VA) with study lenses at Baseline - Sphere and Toric
Distance VA will be assessed for each eye individually with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 spherical contact lenses and DAILIES TOTAL1 for Astigmatism contact lenses.
Baseline
Distance visual acuity with study lenses at Year 1 Follow-up - Sphere and Toric
Distance VA will be assessed for each eye individually with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 spherical contact lenses and DAILIES TOTAL1 for Astigmatism contact lenses.
Year 1 Follow-Up
Distance visual acuity with study lenses at Baseline - Multifocal
Distance visual acuity will be assessed for both eyes together with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 multifocal contact lenses.
Baseline
Distance visual acuity with study lenses at Year 1 Follow-Up - Multifocal
Distance visual acuity will be assessed for both eyes together with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 multifocal contact lenses.
Year 1 Follow-Up
Near visual acuity with study lenses at Baseline - Multifocal
Near visual acuity will be assessed for both eyes together with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 multifocal contact lenses.
Baseline
Near visual acuity with study lenses at Year 1 Follow-Up - Multifocal
Near visual acuity will be assessed for both eyes together with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 multifocal contact lenses.
Year 1 Follow-Up
Incidence of corneal infiltrative events
A corneal infiltrate is a single or group of inflammatory cells in the normally clear cornea.
Up to Year 1
Incidence of microbial keratitis
Microbial keratitis is a sight-threatening infection of the cornea.
Up to Year 1
Study Arms (3)
DAILIES TOTAL1 Sphere
Delefilcon A spherical soft contact lenses worn in both eyes in a real-world setting
DAILIES TOTAL1 Toric
Delefilcon A toric soft contact lenses worn in both eyes in a real-world setting
DAILIES TOTAL1 Multifocal
Delefilcon A multifocal soft contact lenses worn in both eyes in a real-world setting
Interventions
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia)
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with astigmatism
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with presbyopia
Eligibility Criteria
Subjects will be recruited from clinical sites located in the United States.
You may qualify if:
- At baseline: 7 years of age or older for sphere and toric wearers, 40 years of age or older for multifocal wearers.
- Wearers of delefilcon A (sphere, toric, or multifocal) soft contact lenses of the same design in both eyes who have already begun use of the lens type and have purchased at least 3-month supply of lenses at baseline.
- Best corrected distance visual acuity (BCVA) 20/25 or better in each eye at baseline.
You may not qualify if:
- Any ocular disease or condition that would contraindicate contact lens wear at baseline.
- Use of systemic or ocular medications that would contraindicate contact lens wear at baseline.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alcon Researchlead
Study Sites (12)
Westview Optometry
San Diego, California, 92129, United States
Scripps Optometric Group
San Diego, California, 92131, United States
Dr. Walker and Associates
Ponte Vedra Beach, Florida, 32082, United States
Advanced Eyecare Specialists
West Palm Beach, Florida, 33405, United States
The Eye Doctors Inc
Eden Prairie, Minnesota, 55344, United States
Cornea and Contact Lens Institute of Minnesota
Edina, Minnesota, 55436, United States
Complete Eye Care of Medina
Medina, Minnesota, 55340, United States
Koetting Associates
St Louis, Missouri, 63144, United States
Center for Ophthalmic and Vision Research
New York, New York, 10022, United States
Optometry Group, PLLC
Memphis, Tennessee, 38111, United States
Southern Utah Medical Research
St. George, Utah, 84790, United States
Spokane Eye Clinic
Spokane, Washington, 99204, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Clinical Trial Lead, Vision Care
Alcon Research, LLC
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2024
First Posted
July 3, 2024
Study Start
November 26, 2024
Primary Completion
February 27, 2025
Study Completion
February 27, 2025
Last Updated
July 20, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share